Fundz

Vir Biotechnology Appoints Dr. Suzanne Topalian as Class III Director

PUBLIC · VIROct 28, 2026

Position

Director

Company

Vir Biotechnology, Inc.

Suzanne Topalian, M.D.
San FranciscoBiotechnology

Description

On October 26, 2026, Vir Biotechnology's Board of Directors appointed Dr. Suzanne Topalian to fill a newly created vacancy as a Class III director. Dr

Who to call at Vir Biotechnology, Inc., and when

A new leader at Vir Biotechnology, Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Vir Biotechnology, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vir Biotechnology, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vir Biotechnology, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vir Biotechnology, Inc.

Location

499 ILLINOIS STREET

San Francisco, California, United States

About

Vir Biotechnology brings together cutting-edge innovations with scientific expertise and management.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vir Biotechnology, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Jennifer
Likely contact at this company
••••••••@••••••••

See Jennifer's verified email →

Jason
Likely contact at this company
••••••••@••••••••

See Jason's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Vir Biotechnology, Inc.'s next move

Learn about Strategic plan

Vir Biotechnology, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.